Blood test marker study in many cancer types
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study measures a blood marker called progastrin (at diagnosis and during treatment) to see how well it predicts response or outcomes. It may help doctors choose or monitor treatment more precisely for several cancer types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have a confirmed cancer diagnosis (from biopsy/cytology, or strong imaging/suspicion around diagnosis)
- You can sign the study consent form in writing
- You are covered by a social insurance plan
- Your cancer is one of the listed types (breast, stomach, kidney, prostate, lung, liver, colon, head/neck, thyroid, pancreas, ovary, glioblastoma, endometrial, bladder, superficial esophago-gastric, or DLBCL)
- You are starting a planned treatment with either curative (aimed to cure) or non-curative (aimed to control) intent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study is testing whether a simple blood test can help find stomach cancer early, before symptoms appear. This could offer a less invasive way to detect the disease compared to a scope procedure.
This trial studies a simple blood test that may help doctors predict if your digestive cancer (stomach, colon, or pancreatic) has spread to the lining of the belly. The goal is to better plan your treatment and avoid unnecessary surgery.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.